These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effect of modulation of central serotonin neurotransmission on osmoregulated vasopressin release in rats. Faull CM, Charlton JA, Phillips E, Thornton S, Butler T, Baylis PH. Ann N Y Acad Sci; 1993 Jul 22; 689():484-8. PubMed ID: 8396874 [No Abstract] [Full Text] [Related]
10. Involvement of anteroventral third ventricular AMPA/kainate receptors in both hyperosmotic and hypovolemic AVP secretion in conscious rats. Yamaguchi K, Yamada T. Brain Res Bull; 2006 Dec 11; 71(1-3):183-92. PubMed ID: 17113945 [Abstract] [Full Text] [Related]
11. Osmoregulation of vasopressin secretion in the insulin-withdrawn streptozotocin-treated diabetic rat. Charlton JA, Thompson CJ, Palmer JM, Thornton S, Baylis PH. J Endocrinol; 1989 Dec 11; 123(3):413-9. PubMed ID: 2607251 [Abstract] [Full Text] [Related]
12. Osmotic threshold and sensitivity for vasopressin release and fos expression by hypertonic NaCl in ovine fetus. Xu Z, Glenda C, Day L, Yao J, Ross MG. Am J Physiol Endocrinol Metab; 2000 Dec 11; 279(6):E1207-15. PubMed ID: 11093906 [Abstract] [Full Text] [Related]
13. Arginine vasopressin, fluid balance and exercise: is exercise-associated hyponatraemia a disorder of arginine vasopressin secretion? Hew-Butler T. Sports Med; 2010 Jun 01; 40(6):459-79. PubMed ID: 20524712 [Abstract] [Full Text] [Related]
14. Effects of changes in plasma hepatic-portal and systemic osmolality on plasma concentrations of arginine vasopressin in conscious newborn calves. Kati-Coulibaly S, Giry J, Barlet JP. J Dev Physiol; 1989 Oct 01; 12(4):183-7. PubMed ID: 2634058 [Abstract] [Full Text] [Related]
15. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. Albinsson A, Palazidou E, Stephenson J, Andersson G. Eur J Pharmacol; 1994 Jan 14; 251(2-3):157-61. PubMed ID: 8149973 [Abstract] [Full Text] [Related]
16. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms. Dedeoğlu A, Fisher LA. J Pharmacol Exp Ther; 1991 Dec 14; 259(3):1027-34. PubMed ID: 1762059 [Abstract] [Full Text] [Related]